Recent News for GBT - Global Blood Therapeutics, Inc.
Date Title
Jan 14 Global Blood Therapeutics: What The Recent FDA Breakthrough Therapy Designation For Voxelotor Entails
Jan 13 3 Biotech Stocks That Soared This Week: Are They Buys?
Jan 11 Global Blood Therapeutics: Grade 'A' Opportunity
Jan 11 Global Blood Therapeutics: Telegraphing Positive HOPE Part A Results
Jan 10 Selling Action Is Upon Us
Jan 9 Healthcare Stocks Breakout: Pain Therapeutics, Inc. (PTIE), Global Blood Therapeutics Inc (GBT)
Jan 9 Why Global Blood Therapeutics Inc Is Rising Today
Jan 9 40 Stocks Moving In Tuesday's Mid-Day Session
Jan 9 Healthcare - Top 5 Gainers / Losers as of 11:00 am
Jan 9 Global Blood's voxelotor a Breakthrough Therapy for sickle cell disease; shares ahead 19%
Jan 9 Premarket Gainers as of 9:05 am
Jan 9 GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)
Jan 3 GBT to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 27 Global Blood Therapeutics: The Significance Of ASH Updates
Dec 22 GBT Appoints Wendy L. Yarno to Board of Directors
Dec 21 Daily Insider Ratings Round Up 12/19/17: BAS, GBT, PSEC, DRNA, SLNO
Dec 20 Upcoming Conversation With An Expert: What's The Potential Of Global Blood Therapeutics' Voxelotor (GBT440) In Sickle Cell Disease After Data Released At ASH 2017
Dec 20 Jonathan Faison Positions For 2018: Faster FDA Approval, Emerging Sector In China Bode Well For Biotech Next Year
Dec 19 Oppenheimer Serves Up 29 Top Stock Ideas For January
Dec 18 33 Biggest Movers From Friday
Dec 15 30 Stocks Moving In Friday's Mid-Day Session
Dec 15 Global Blood executes $100M at-the-market stock offering; shares down 6%
Dec 15 Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
Dec 15 25 Stocks Moving In Friday's Pre-Market Session
Dec 15 5 Stocks To Watch For December 15, 2017

Back to the Main GBT Page...